Abstract Body

Background:

Despite the high sensitivity and specificity by confirmatory serological tests for HTLV infection, numerous cases with untyped or indeterminate results are reported, mainly for HTLV-2 infection. New approaches are urgently needed, especially among volunteer blood donors and individuals co-infected with some persistent viruses. Therefore, the aim of this study was to analyze a new Multiplex-ELISA (Multi-HTLV/InfYnity Biomarkers) confirmatory serological methodology for HTLV-½.

Methods:

For this purpose, we performed a comparative analysis between the molecular methodology of PCR-RFLP and Multiplex, with 254 plasma samples.

Results:

In molecular assays (nested-PCR for HTLV-½), 128 samples were identified as positive for HTLV-1, 119 for HTLV-2 and 7 for co-infection of both types (HTLV-1+2). Among the samples confirmed as HTLV-1 by the gold standard methodology, 122/128 (95%) showed positive validation and reactivity to HTLV-1 discriminating proteins by the Multiplex; 4% (4/128) had indeterminate or differently typed results to RFLP and only 0.78% (1/128) showed false-negative results. However, for the HTLV-2+ cases by molecular assays, 85% (101/119) were positive and correctly discriminated. Approximately 13% had indeterminate or incorrectly discriminated results and two cases (2/119; 1.7%) had false-negative results. For the co-infected samples (HTLV-1+2), the multiplex did not yield any results according to PCR-RFLP. Of these, 57.14% (4/7) showed reactivity to discriminatory proteins for HTLV-1, 29% (2/7) for HTLV-2 proteins and 14% (1/7) had indeterminate results.

Conclusions:

It is important to emphasize that the molecular PCR-RFLP techniques performed by this study showed better efficacy for the diagnosis of HTLV-2 when compared to Multi-HTLV. However, studies show that confirmatory serological results, such as the Western Blot, when compared to the same diagnostic technologies, present similar results, or even lower to the Multiplex/ELISA for this group of individuals. Becoming the closest serological technique to the effectiveness of molecular tests, considered “gold standard” for diagnosis of this infection. Discrepant results need to be further investigated to align serology with PCR techniques.

FIGURE 1: Comparative flowchart between PCR-RFLP results and Multi-HTLV results. PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; Multi-HTLV: Multiplex-ELISA/Infynity Biomarkers.